.
MergerLinks Header Logo

Announced

Advent International to acquire a majority stake in Avra Laboratories for $100m.

Financials

Edit Data
Transaction Value£76m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Private Equity

Majority

Pending

Private

Acquisition

India

Single Bidder

Friendly

Cross Border

active pharmaceutical ingredients

Pharmaceuticals

Synopsis

Edit

Advent International, a private equity firm, agreed to acquire a majority stake in Avra Laboratories, an active pharmaceutical ingredients manufacturer, for $100m. “This acquisition is an important milestone towards our goal of creating a top five merchant API Platform in India and allows Advent to be present across the spectrum of generic and patented molecules, while adding marquee innovator pharma customers," Pankaj Patwari, Advent International India Managing Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US